Axcellerate Pharma deploys a unique combination of assets and operational capabilities to provide high quality CRO and CDMO services. Axcellerate Pharma is ideally positioned to accommodate drug product development activities as well as the manufacture of early cGMP clinical supplies of drug substance and sterile drug product for both large and small molecules. Axcellerate’s capabilities include a full complement of organic synthesis, analytical methods development and biological services. In addition, Axcellerate Pharma has dedicated process areas for biologics development, chemical development and sterile manufacturing of drug product including lyophilization.
Axcellerate Pharma offers expertise in the manufacture of various types of Services. Please click here to learn more about our services.
Axcellerate Pharma have capabilities in many areas. Please click here to learn more about our capabilities.
Corporate Presentation & our capabilities
Please enter your information to download
You have Successfully Subscribed!
March 20 – 23
March 21 – 23
Interphex, New York
May 16 – 18
CPhI North America, Philadelphia
Commercial Manufacturing | CRO/CDMO
Hormones & Steroids
Mammalian Cell Culture